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Study of oligoclonal bandS reStricted 
to the cerebroSpinal fluid in multiple 
ScleroSiS patientS in the city of São paulo
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abstract – The frequency of oligoclonal bands (OCB) restricted to the cerebrospinal fluid (CSF) from patients 
with multiple sclerosis (MS) varies widely in different populations. The objective of this study was to determine 
the frequency of these OCB in a group of MS patients in the city of São Paulo. Techniques used to detect OCB 
consisted of isoelectric focusing followed by immunoblotting. Oligoclonal bands were found in 49 (54.4%) 
out of 90 patients with clinically definite MS; in (31.2%) of the 16 patients with clinically isolated syndrome; 
in 7 (17.9%) of 39 patients with inflammatory disorders of the central nervous system (IDCNS), and in none of 
the individuals with no neurological condition (control group). The specificity of the method was 100% when 
compared to the control group and 82.1% when compared to the IDCNS group. These results suggest that the 
frequency of CSF OCB is much lower in Brazilian MS patients from São Paulo city than that reported in MS 
series from Caucasian populations. 
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estudo de bandas oligoclonais restritas ao líquido cefalorraquidiano em pacientes com esclerose múltipla 
na cidade de São paulo
resumo – A frequência da detecção de bandas oligoclonais (BOC) restritas ao líquido cerebrorraquidiano 
(LCR) em pacientes com esclerose múltipla (EM) varia amplamente em diferentes populações. O objetivo 
deste estudo foi determinar a frequência destas BOC em pacientes com EM em amostra de população da 
cidade de São Paulo. A técnica utilizada para a detecção das BOC foi a focalização isoelétrica, seguida do 
immunoblotting. BOC foram detectadas: em 49 (54,4%) de 90 pacientes com EM clinicamente definida; em 5 
(31,2%) de 16 pacientes com síndrome clínica isolada; em 7 (17,9%) de 30 pacientes com doenças inflamatórias 
do sistema nervoso central (DISNC); e em nenhum indivíduo sem doença neurológica. A especificidade do 
método foi 100% quando comparada ao grupo controle e 82,1% quando comparada ao grupo de DISNC. 
Estes resultados sugerem que a freqüência de BOC no LCR é mais baixa em pacientes da cidade de São Paulo 
portadores de EM do que aquelas descritas em populações caucasianas.
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Department of Neurology and Neurosurgery of the Faculty of Medicine of University of São Paulo (USP), São Paulo SP, Brazil: 1Assistant Professor, 
Pontifical Catholic University of São Paulo, São Paulo SP, Brazil; 2Post-Graduate Student of Neurology, USP; 3Associate Professor of Neurology, USP; 
4Neurologist, USP; 5Associate Professor of Neurology and Ophthalmology, Federal University of Minas Gerais, Belo Horizonte MG, Brazil; 6Associate 
Professor and Responsible for the Demyelinating Diseases Reference Center of the Clinical Hospital of the Faculty of Medicine University of São Paulo 
and the Brazilian Committee for Treatment and Research in Multiple Sclerosis (BCTRIMS), Belo Horizonte MG, Brazil.
Received 24 May 2009, received in final form 20 July 2009. Accepted 7 August 2009.
Dr. Paulo Diniz da Gama – Rua Conde Francisco Matarazzo 58 - 18030-010 Sorocaba SP - Brasil. E-mail: inst.cerebro@globo.com
Multiple sclerosis (MS) is an inflammatory central ner-
vous system (CNS) disorder, increasingly diagnosed in trop-
ical countries. The anatomical substrate is the finding of 
inflammation, demyelination, axonal degeneration and gli-
osis. Although its etiology still remains a mystery, autoim-
mune mechanisms must play an essential role in its patho-
genesis1-4. MS diagnosis is still largely based upon clinical 
evidences. However, magnetic resonance imaging (MRI), 
and cerebrospinal fluid (CSF) analysis are important tools 
for recognizing the topography, extent, phase of the le-
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sions, characterization of the local immune response and 
differential diagnosis with other neurological diseases2,5,6.
CNS inflammation in MS can be estimated by intrathe-
cal production of immunoglobulins (IgG). This production 
can be assessed by the finding of IgG bands in the CSF sys-
tem without a clear recognition of the same bands in the 
serum, i.e. CSF oligoclonal bands (OCB)1,6. 
Different MS populations living in different countries 
appear to have different prevalence rates of CSF OCB. The 
prevalence rate is as high as 90 to 95% in Scandinavia7-9, 
and as low as 30 to 60% in China, Japan, Lebanon and In-
dia10-13. We describe the frequency of OCB in the CSF of a 
group of MS patients in the city of São Paulo, Brazil.
method
The cohort comprised 164 patients seen at the Demyelinat-
ing Disorders Outpatient Clinics of the University of São Paulo 
Medical School. All patients or their legal guardians signed the 
informed consent agreement. The study was authorized by the 
Research Ethics Committee of the institution.
The patients’ history, physical examination and analysis of 
the MRI were all done at the first visit, and then re-evaluated by 
a second researcher. Both researchers were neurologists with ex-
pertise in MS diagnosis. Diagnosis was based upon the interna-
tional criteria of McDonald, revised in 200514.
Serological tests (hemogram; erythrocyte sedimentation 
rate; urea and creatinine; transaminases; total and fractionat-
ed bilirubin; glycemia; calcium; free thyroxin; thyroid-stimulat-
ing hormone; C-reactive protein; anti-nuclear factor; latex test, 
fractions of the complement, anticardiolipin antibodies; cyano-
cobalamin and folate dosage; immunological reactions for syph-
ilis, hepatitis B and C, HIV and HTLV) were requested to exclude 
diseases that could have differential diagnosis with MS.
No OCB investigation was made previously in CSF from 
these patients. So, the results of the CSF analysis were not used 
to establish the diagnosis or to include patients in this study.
We divided subjects into four different groups. Group 1 
comprised 90 patients with clinically-definite multiple sclero-
sis (CDMS) according to McDonald’s criteria14: 61 with relapsing 
remitting form (RR); 11 with secondary-progressive form (SP); 16 
with primary-progressive form (PP); 2 with progressive relapsing 
form (PR). Group 2 comprised 16 individuals who presented a 
clinically isolated syndrome (CIS) indicative of a CNS first demy-
elinating event. Group 3 comprised 39 patients with a variety of 
chronic inflammatory disorders of the CNS. Group 4 comprised 
19 subjects with neither neurological complaints nor infectious 
conditions, whose CSF sample was collected during anesthetic 
procedure for minor surgery. 
Blood serum and CSF analysis were carried out simultaneous-
ly. The CSF analysis included the classical routine tests (cytomor-
phological profile; determination of total protein content; dos-
age of glucose) and immunological reactions for the infectious 
diseases more frequently observed in tropical countries2,3,6.
The technique used to assess the OCB was isoelectric fo-
cusing (IF) in polyacrylamide gel (ETC – Elektrophorese – Tech-
nok Bahnhofstr). Each paired sample of CSF and blood serum 
was submitted to IF (CWP-400 Isolab Inc) always with a positive 
control. IF was transferred to a nitrocellulose membrane (Bio 
Agency), followed by immunoblotting using a primary antibody 
(Goat-anti-human IgG, Sigma) and a polyclonal rabbit anti-goat 
immunoglobulin (Dako Cytomation) as a secondary antibody. 
Subsequently, the reaction was developed using 3-amino-9-eth-
ylcarbazole (Sigma). OCB were considered recognized when two 
or more bands were found in the CSF, but absent in the serum. 
All IF were examined by two specialists who were not aware to 
which group the samples belonged. In a case of discrepant or du-
bious interpretation of results, the sample was processed again.
Quantitative intrathecal immunoproduction of IgG was car-
ried out in parallel. Concentrations of IgG and albumin both in 
the serum and CSF were measured by nephelometry. This al-
lowed to determine: (1) the CSF/serum ratio for IgG or IgG quo-
tient (IgGQ) and the CSF/serum ratio for albumin or albumin 
quocient (AQ); (2) IgG index (the ratio between IgGQ and AQ); (3) 
Reiber and Felgenhauer nomogram. 
AQ values were considered increased for values of 6,5 × 10–3 
or higher. AQ over 8 x 10
–3 in patients with more than 40 years 
are considered normal. IgG index was considered increased for 
values ≥0.8. 
reSultS
Table 1 shows the demographic characteristics of the 
patients.
Out of the 90 patients with CDMS, 49 (54.4%) present-
ed OCB restricted to the CSF. These OCB were detected 
in 21 out of 41 CDMS patients (51.2%) who were in use of 
immunomodulatory agents. Fig 1 shows the frequencies of 
positive CSF OCB according to the clinical course of MS 
(27 RR, 6 SP, 14 PP and 2 PR). 
The sensitivity of OCB in patients with MS in our study 
was 54.4%. The specificity was 100% when patients with-
out neurological disease were used as controls; 82.1% 
when patients with inflammatory diseases of the CNS 
were used as the control. These data, together with the 
accuracy and the positive and negative predictor values 
are shown in Table 2.
As shown in Fig 1, OCB were more frequent in progres-
sive forms (PP, SP and PR) than in RR form of MS (p=0.009). 
In the group of patients with CIS, positive CSF OCB 
were found in 5 (31.2%) out of 16 patients. There was no 
statistical difference between the frequency of OCB in pa-
tients with CIS when compared to patients with RR form 
of MS (p=0.35) (Fig 1).
OCB were found in 7 (17.9%) out of 39 patients with in-
flammatory diseases of the CNS. This frequency is much 
smaller than that observed for the pool of MS patients 
(p=0.00002) and for the subgroup of patients with RR 
form of MS (p=0.001).
No OCB were found in patients from the control group. 
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Table 3 shows the frequency of positive OCB in the 
CSF of patients with a variety of inflammatory diseases 
of the CNS. The frequencies of OCB in the CSF of MS pa-
tients in different populations worldwide are shown in 
Table 4.
The IgG index was abnormal in 42 of the 90 patients 
with CDMS (46.6%), with a median of 0.8, media of 1.02 
Table 1. Demographic characteristics of the studied population.
Groups N Age media
Gender
F/M
Ethnical origin
European African
MS 90 35.6±12.1 2.9/1 72% 18%
CIS 16 25.4± 8.2 2.2/1 81% 19%
ID 39 31.5±18.4 2.3/1 54% 46%
NNC 19 39.2±16.2  2.2/1 63% 37%
N: number; MS: multiple sclerosis; CIS: clinical isolated syndrome; ID: inflammatory disease of the central nervous 
system; NNC: no neurological complain.
Table 2. Indicators of significance in the detection of OCB for 
the diagnosis of multiple sclerosis, using the isoelectric focusing 
technique followed by immunoblotting.
OCB in multiple sclerosis
Control
group (%)
ID 
group (%)
Sensitivity 54.4 54.4
Specificity 100 82.1
Accuracy 77.2 68.2
Positive predictor value 100 75.2
Negative predictor value 68.6 64.2
OCB: oligoclonal bands; control group: patients submitted to spinal tap for 
anesthesia; ID group: inflammatory diseases of the central nervous system.
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87.5
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0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
CIS n=16 RR n=61 SP n=11 PP n=16 PR n=02
OCB + OCB –
Fig 1. Correlation between the clinical forms of multiple sclerosis and 
analysis of cerebrospinal fluid. CIS: clinically isolated syndrome; RR: 
relapsing remitting; SP: secondary-progressive; PP: primary-progres-
sive; PR: progressive relapsing; OCB: oligoclonal bands by isoelectric 
focusing and immunoblotting. No-association test for CIS and RR: 
p=0.35 and RR to progressive forms: p=0.009.
Table 3. Frequency of restricted oligoclonal bands to the 
cerebrospinal fluid in patients with inflammatory diseases of 
the central nervous system. 
OCB+
n n %
Relapsing optic neuritis 2 2 100
HTLV myelopathy 2 1 50
Schistosomiasis 2 1 50
CNS vasculitis 15 3 20 
Neuromyelitis optica 6 0 0
Relapsing myelitis 4 0 0
ADEM 3 0 0
Hepatitis B and C 3 0 0
Syphilis 1 0 0
Viral optic neuritis 1 0 0
OCB+: presence of oligoclonal bands by isoelectric focusing and immunoblotting); 
n: number of patients; CNS: central nervous system; ADEM: acute disseminated 
encephalomyelitis.
(SD 0.67). Sensitivity of the IgG index for the diagnosis 
of MS was 46.6%; specificity was 94.8% when patients 
without neurological disease were used as controls, and 
64.2% when patients with inflammatory diseases of the 
CNS were used as controls. 
There was concordance between the presence of OCB 
and increased IgG index in 37 patients with MS (41.1%). De-
tection of OCB and/or increased values of IgG index may 
allow to characterize the CSF immunoproduction of IgG 
in 57 out of 90 patients (63.3%). 
In the group of patients with inflammatory diseases 
of the CNS, increased IgG index was found in 14 of 39 pa-
tients (35.8%). 
 In the control group, one of the 19 patients present-
ed a slight increase in IgG index (5.2%).
Reiber and Felgenhauer nomogram for quantitative 
evaluation of immunoproduction is shown in Fig 2. The 
comparative study of qualitative (OCB) and quantitative 
IgG immunoproduction (IgG index) is shown in Fig 3. 
The median cell count in the CSF was 5 cell/mm3. 
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Pleocytosis up to 30 cells/mm3 (mononuclear cells) was 
seen in 51.7% of the patients. In 98.1% of the patients with 
MS, the total protein content (mean: 31.3 mg/dl, SD: 7.2, 
median: 29 mg/dL) was below 72 mg/dl and the total cell 
count was below 30 cells/mm3. Glucose concentration 
was normal in all patients. QA was high in 14.1%, suggesting 
some degree of dysfunction of the blood-CSF barrier. 
All immunological tests showed either normal results 
or slight alterations without clinical significance.
diScuSSion
Our study showed that 54.4% of the patients with 
CDMS had OCB restricted to the CSF. The sensitivity of 
this finding was 100% when compared to patients with-
out neurological diseases, and 82.1% when compared to 
patients with inflammatory diseases of the CNS. 
The frequency of OCB found in this study is low in 
comparison with both the prevalence observed in Euro-
pean and North-America MS patients and other previous 
Brazilian studies which found a frequency of 85%17 and 
91%18. However, this low rate is similar to that observed in 
other regions of the world (Table 4). 
Three main hypotheses may be postulated to explain 
the lower results for OCB detection in our study: (a) there 
was a bias in clinical evaluation of the patients included; 
(b) there were problems in methodology for CSF analy-
sis of these patients; (c) OCB does occur in a smaller per-
centage in São Paulo city by unknown reasons. 
As for the first hypothesis, a special and intensive care 
was taken to include only patients with MS clinical def-
inite. The inclusion criteria strictly followed recommen-
dations for MS diagnosis, widely discussed in the interna-
tional panel of McDonald revised in 200514. These patients 
were carefully and independently examined by two expe-
rienced neurologists, with expertise in MS diagnosis and 
treatment. Therefore, this hypothesis is highly unlikely to 
explain this finding.
As for the second hypothesis, some considerations 
must be made: (1) the results of CSF analysis were not 
used as an inclusion criteria; (2) our study was carried out 
in an academic reference laboratory with a very experi-
enced research staff in CSF analysis, mainly in electro-
phorectic methods. The CSF sample was processed us-
ing high standards according to CSF Analysis Consensus 
of Freedman MS et al.6. This included the use of the most 
up-to-date internationally accepted technology and strict 
adherence to the criteria of reproducibility ensuring high 
levels of fidelity of the results; (3) the IF method followed 
by immunoblotting used in our patients is the most sensi-
tive and suitable technique for detecting OCB when MS is 
suspected6. Nevertheless, the use of this technique is not 
a universal practice: according to the College of American 
Pathologists Survey16, only 10% of the 235 laboratories in 
the USA that conduct CSF analysis use this technique to 
detect OCB. This clearly shows that, unlike our group, in 
practice, the most suitable method for investigating OCB 
has been underutilized in many research centers, even in 
the most developed countries; (4) the analysis of paired 
CSF and serum electrophoresis was made by two skilled 
Fig 2. Quotient of immunoglobulin plotted against the quotient of al-
bumin for the three groups of patients. QIgG: IgG quocient; QAlb: al-
bumin quocient; region 1: normal; region 2: blood-brain barrier break-
down; region 3: blood-brain barrier breakdown associated with local 
synthesis; region 4: local synthesis.
Fig 3. Comparison of the frequency of positive oligoclonal bands and 
IgG index ≥0.8 in the cerebrospinal fluid of patients with different 
central nervous system disorders and controls. MS: multiple sclero-
sis; CIS: clinically isolated syndrome; ODD: other demyelinating dis-
ease, include neuromyelitis optica, acute disseminated encephalo-
myelitis, relapsing myelitis and relapsing optic neuritis; controls: pa-
tients submitted to spinal tap for anesthesia.
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researchers unaware of the diagnosis of the patients. So, 
the low frequency of OCB founded in this study may not 
be ascribed to problems in CSF analysis.
Apart from the relatively low sensitivity, the detection 
of OCB seemed to have a low specificity, mainly when a 
blind method of analysis was used7,8. OCB have been de-
scribed in other inflammatory diseases, their frequency 
of detection ranging from 25 to 80%5,7,19, as well as in non-
inflammatory diseases of the CNS (in up to 17% of pa-
tients15). However, there is no consensus about this low 
specificity of OCB in MS.9,20,21.
In the MS group, OCB were observed more frequent-
ly in progressive forms than in RR form. This may be ex-
plained by the continuous course of the disease and a 
consequent more effective exposition to immunological 
mechanisms in those forms of MS. 
On the other hand, the frequency of OCB observed 
in patients with CIS is similar to that observed in patients 
with RR form of MS. This observation may give rise to 
two comments: (a) CIS is a true form of MS; (b) our clin-
ical appraisal of patients included in this study was ful-
ly satisfactory. 
The quantitative determination of immunoproduction 
of IgG must be made in addition to OCB search. This com-
plementary method seems to improve the sensitivity of 
CSF diagnosis in MS, since 8.9% of patients with definite 
MS diagnosis presented increased IgG index without OCB 
in CSF. However, it remains to be explained why this dif-
ference occurs and what is the meaning of this finding. 
The relatively low frequency of increased AQ observed 
in CSF samples studied suggests that our MS patients do 
not often have impairment of the blood-brain-barrier 
(BBB) function.
The Reiber and Felgenhauer nomogram is a very inter-
esting quantitative method to evaluate CSF intrathecal 
IgG production. It permits to recognize: (1) the patients 
in which no IgG immunoproduction nor BBB breakdown 
is happening (region 1 of Fig 2); (2) the occurrence of BBB 
breakdown, more usually seen in inflammatory diseases 
other than MS (region 2 of Fig 2); (3) the association of 
immunoproduction and BBB breakdown as it is shown in 
the region 3 of the Fig 2. This characteristic may be im-
portant in patients with MS, since it is probably the only 
complementary diagnostic method that allows recogni-
Table 4. Frequency of oligoclonal bands restricted to the cerebrospinal fluid of patients with multiple sclerosis 
in different countries.
Country Method
% OCB +  
ReferencesMS ID Control
Norway IEF IF 100% 9% Lunding J et al. 20009
Slovenia IEF IF 95% Rot et al. 20088
Norway IEF IB 93% 67% 4% Mygland A et al. 20077
USA IEF IB 90% 6% Fortini AS et al. 200320
Canada IEF IB 89% Siritho S et al. 200926
Italy IEF 89% Annunziata P et al. 200627
Spain IEF IB 87% 52% 17% Falip M et al. 200115
France IEF 85% 21% 8% Bourahoui A et al. 200428
Portugal IEF IF 82% 40% 3% Sá MJ et al. 200519
Czech Rep. IEF IB 81% 7% Bednarova et al. 200529
Holland IEF IF 76% Koch M et al. 200730
France IEF IF 76% 7% Fromont A et al. 200521
China IEF SS 63% 47% 4% Li B et al. 200710
Japan IEF IF SS 56% Fukazawa et al. 199811
China NR 40% Lau KK et al. 200223
Lebanon NR 40% Yamout B et al. 200812
Japan IEF 33% Tanaka K et al. 200524
India NR 30% Syal P et al. 199913
Taiwan IEF 7% 0% Chang KH et al. 200631
brazil ief ib 54% 17% 0% present study
ID: inflammatory diseases of the central nervous system; IEF: isoelectric focusing; IB: immunoblotting; IF: immunofixation; SS: silver staining; 
NR: no reference.
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tion of the acute phase phenomena (BBB breakdown) tak-
ing place over an older chronic immunoproducing pro-
cess. This information may be helpful for distinction when 
images seen at MRI may correspond to acute lesions or 
only to cicatricial demyelination; (4) the graphic represen-
tation of samples from patients with IgG immunoproduc-
tion is displayed in a similar way to that of the Link’s IgG 
index analysis (region 4 of Fig 2).
Although CSF analysis in MS aims to characterize the 
local immune response in the CNS, a number of other 
features may differentiate MS from other diseases of the 
CNS, such as: (1) in MS, there is usually a high number of 
OCB; (2) in MS, the simultaneous presence of OCB in CSF 
and in the blood serum is uncommon, even if a high num-
ber of bands have been identified in the CSF; (3) there usu-
ally is a normal number of cell count or a slight pleocyto-
sis, usually below 30 cells/mm3, with an absolute predom-
inance of lymphomononuclear cells; (4) the total protein 
content is usually normal or slightly above normal, gen-
erally below 70 mg/dL; (5) the concentration of glucose 
should be within reference limits2-4,20.
These data show the importance of the CSF analysis in 
all MS patients, mainly in those with initial clinical symp-
toms of demyelinating diseases. The detection of this CSF 
profile may be helpful to suggest the occurrence of an 
inflammatory process in the CNS, especially in patients 
whose clinical and imaging abnormalities are not clear-
cut, thus providing the possibility of early diagnosis and 
treatment8,25. This is more important in progressive forms 
of MS, mainly in the primary progressive form.
In conclusion, the expected results for the frequency 
of OCB in MS patients in Brazil cannot be estimated by 
simple extrapolation from the data obtained in European 
or North American populations. Possibly, variations in the 
clinical presentation and genetic susceptibility may deter-
mine the occurrence of significant variations11,22-24. 
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